Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer

  1. Julie Pilotte,
  2. Daniel Larocque, and
  3. Stéphane Richard1
  1. Terry Fox Molecular Oncology Group and the Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and Departments of Oncology, Medicine, Microbiology and Immunology, McGill University, Montréal, Québec, H3T 1E2, Canada

Abstract

The quaking viable mice have myelination defects and develop a characteristic tremor 10 d after birth. The quaking gene encodes at least five alternatively spliced QUAKING (QKI) isoforms that differ in their C-terminal 8–30-amino-acid sequence. The reason for the existence of the different QKI isoforms and their function are unknown. Here we show that only one QKI isoform, QKI-7, can induce apoptosis in fibroblasts and primary rat oligodendrocytes. Heterodimerization of the QKI isoforms results in the nuclear translocation of QKI-7 and the suppression of apoptosis. The unique C-terminal 14 amino acids of QKI-7 confers the ability to induce apoptosis to heterologous proteins such as the green fluorescent protein and a QKI-related protein, Caenorhabditis elegansGLD-1. Thus, the unique C-terminal sequences of QKI-7 may function as a life-or-death ‘sensor’ that monitors the balance between the alternatively spliced QKI isoforms. Moreover, our findings suggest that nuclear translocation is a novel mechanism of inactivating apoptotic inducers.

Keywords

Footnotes

  • 1 Corresponding author.

  • E-MAIL sricha{at}po-box.mcgill.ca; FAX (514) 340-8295.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.860301.

    • Received October 9, 2000.
    • Accepted January 31, 2001.
| Table of Contents

Life Science Alliance